Yanlin Zhu

786 total citations
38 papers, 559 citations indexed

About

Yanlin Zhu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yanlin Zhu has authored 38 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Yanlin Zhu's work include Drug Transport and Resistance Mechanisms (6 papers), Cardiovascular Function and Risk Factors (5 papers) and Viral Infections and Immunology Research (5 papers). Yanlin Zhu is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Cardiovascular Function and Risk Factors (5 papers) and Viral Infections and Immunology Research (5 papers). Yanlin Zhu collaborates with scholars based in China, United States and Russia. Yanlin Zhu's co-authors include Lihua Jin, Weili Zheng, Yong Li, Mingshe Zhu, Wei Tang, Fusheng Guo, Weiqing Chen, Qingjun Wu, Yan Zhao and Yaping Han and has published in prestigious journals such as ACS Nano, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Yanlin Zhu

35 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanlin Zhu China 12 123 105 92 87 80 38 559
Haran Yogasundaram Canada 13 208 1.7× 288 2.7× 32 0.3× 126 1.4× 39 0.5× 31 768
Kazushi Sakurai Japan 10 130 1.1× 63 0.6× 66 0.7× 55 0.6× 28 0.3× 18 520
Fahri Şahin Türkiye 19 261 2.1× 32 0.3× 56 0.6× 72 0.8× 158 2.0× 102 1.1k
Chibo Liu China 17 463 3.8× 38 0.4× 58 0.6× 118 1.4× 85 1.1× 48 904
Irina Buhăescu Romania 12 319 2.6× 109 1.0× 132 1.4× 67 0.8× 86 1.1× 18 838
Hui Gong China 14 255 2.1× 57 0.5× 51 0.6× 81 0.9× 89 1.1× 57 596
Preben Jakobsen Denmark 17 220 1.8× 82 0.8× 49 0.5× 52 0.6× 193 2.4× 36 815
T. Stief Germany 18 223 1.8× 118 1.1× 253 2.8× 92 1.1× 50 0.6× 98 1.2k
K Ishii Japan 11 100 0.8× 40 0.4× 33 0.4× 71 0.8× 41 0.5× 52 411
Zeyu Wang China 16 288 2.3× 79 0.8× 205 2.2× 119 1.4× 41 0.5× 55 901

Countries citing papers authored by Yanlin Zhu

Since Specialization
Citations

This map shows the geographic impact of Yanlin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanlin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanlin Zhu more than expected).

Fields of papers citing papers by Yanlin Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanlin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanlin Zhu. The network helps show where Yanlin Zhu may publish in the future.

Co-authorship network of co-authors of Yanlin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanlin Zhu. A scholar is included among the top collaborators of Yanlin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanlin Zhu. Yanlin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Zhen, et al.. (2025). TD U-Net for Shell Segmentation and Thickness Evaluation in Core–Shell TiO2 TEM Images. Materials. 18(21). 5007–5007.
2.
Liu, Yang, et al.. (2025). A FUT2-β-catenin axis mediates chemoresistance and cancer stemness in lung adenocarcinoma. Cellular Signalling. 135. 112057–112057.
3.
He, Yu, et al.. (2024). Enhancement on the thermal and tribological behaviors of polyurethane/epoxy-based interpenetrating network composites by orientationally aligned CNF/MXene/WPU aerogels. Composites Part A Applied Science and Manufacturing. 187. 108477–108477. 11 indexed citations
5.
Zhu, Yanlin, Sitong Wu, Feng Guo, et al.. (2024). Structural characteristics of sulfated xylogalactomannan isolated from Caulerpa okamurae and its anticoagulant activity. International Journal of Biological Macromolecules. 275(Pt 2). 133743–133743. 7 indexed citations
6.
Wang, Xinxin, Jianmin Zhou, Yanlin Zhu, et al.. (2024). Dual-doped metalloporphyrin MOFs-based nanoagent increases low-dose radiotherapy efficacy by apoptosis-ferroptosis for hepatocellular carcinoma. Chemical Engineering Journal. 501. 157645–157645. 6 indexed citations
7.
Zhu, Yanlin, et al.. (2024). Deferoxamine Treatment Effectively Prevents Periodontitis Progression by Reducing Inflammation and Osteoclastogenesis in Experimental Periodontitis Rats. Journal of Inflammation Research. Volume 17. 9637–9650. 3 indexed citations
8.
Zhu, Yanlin, et al.. (2024). Evaluation of Thermal and Mechanical Properties of Bi-In-Sn/WO3 Composites for Efficient Heat Dissipation. Materials. 17(21). 5315–5315. 2 indexed citations
9.
Liu, Xiaohang, Dingding Zhang, Xue Lin, et al.. (2022). Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study. BMC Cardiovascular Disorders. 22(1). 175–175. 6 indexed citations
10.
Guo, Fusheng, Yanlin Zhu, Yaping Han, et al.. (2022). DEPP Deficiency Contributes to Browning of White Adipose Tissue. International Journal of Molecular Sciences. 23(12). 6563–6563. 3 indexed citations
11.
Liu, Yongtai, Jinzhi Lai, Fei‐Fei Zhai, et al.. (2021). Right ventricular systolic function is associated with health-related quality of life: a cross-sectional study in community-dwelling populations. Annals of Translational Medicine. 9(8). 640–640. 3 indexed citations
12.
Liu, Yingxian, Ligang Fang, Wei Chen, et al.. (2020). Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies. Cardiovascular Diagnosis and Therapy. 10(3). 405–420. 28 indexed citations
13.
Zhu, Yanlin, Shuangshuang Xu, Yi Lu, et al.. (2020). Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD. Frontiers in Pharmacology. 11. 590–590. 17 indexed citations
14.
Liu, Xiaohang, Jiayu Shi, Yingxian Liu, et al.. (2020). The quest for diagnostic approaches of cardiac involvement in polymyositis and dermatomyositis. Annals of Palliative Medicine. 9(4). 2256–2270. 12 indexed citations
16.
Lu, Yi, Yanlin Zhu, Weili Zheng, et al.. (2018). Structural basis for the hepatoprotective effects of antihypertensive 1,4-dihydropyridine drugs. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(10). 2261–2270. 8 indexed citations
17.
Zheng, Weili, Yi Lu, Shengchen Lin, et al.. (2017). A Novel Class of Natural FXR Modulators with a Unique Mode of Selective Co‐regulator Assembly. ChemBioChem. 18(8). 721–725. 24 indexed citations
18.
Lu, Yi, Weili Zheng, Shengchen Lin, et al.. (2017). Identification of an Oleanane-Type Triterpene Hedragonic Acid as a Novel Farnesoid X Receptor Ligand with Liver Protective Effects and Anti-inflammatory Activity. Molecular Pharmacology. 93(2). 63–72. 32 indexed citations
19.
Jin, Lihua, Rui Wang, Yanlin Zhu, et al.. (2015). Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease. Scientific Reports. 5(1). 17288–17288. 37 indexed citations
20.
Zhu, Yanlin, et al.. (2013). Amlodipine Metabolism in Human Liver Microsomes and Roles of CYP3A4/5 in the Dihydropyridine Dehydrogenation. Drug Metabolism and Disposition. 42(2). 245–249. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026